Japan· JP-4291447D1028
トラスツズマブ（遺伝子組換え）［トラスツズマブ後続３］
A medicinal product containing トラスツズマブ（遺伝子組換え）［トラスツズマブ後続３］, registered in Japan by ファイザー, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- トラスツズマブ（遺伝子組換え）［トラスツズマブ後続３］
- Manufacturer
- ファイザー
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- October 2, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
トラスツズマブ（遺伝子組換え）［トラスツズマブ後続３］ in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHerceptin 150mg powder for concentrate for solution for infusion vialsRoche Products Ltd
- FinlandDazublysCuraTeQ Biologics (Malta) Limited
- CzechiaDAZUBLYSCuraTeQ Biologics (Malta) Limited, Floriana
- BelgiumDazublys 150 mgCuraTeQ Biologics (Malta)
- SwedenDazublys 150 mg Pulver till koncentrat till infusionsvätska, lösningCuraTeQ Biologics (Malta) Limited
- PolandDazublysCuraTeQ Biologics s.r.o.
- IcelandDazublysCuraTeQ Biologics (Malta) Limited
- IrelandDazublys 150 mg powder for concentrate for solution for infusionCurateq Biologics s.r.o.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Dazublys, Herceptin
- Liechtenstein · Dazublys, Herceptin
- Norway · Dazublys, Herceptin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/13748aa5-6d7f-4f5c-86a1-ac6b956566d3 GET /v1/drugs/13748aa5-6d7f-4f5c-86a1-ac6b956566d3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "６０ｍｇ１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "4291447D1028",
"category": "注射薬",
"price_yen": 3960,
"generic_name": "トラスツズマブ（遺伝子組換え）［トラスツズマブ後続３］",
"product_name_jp": null,
"therapeutic_class": "4291",
"transitional_expiry": null
}See everything about トラスツズマブ（遺伝子組換え）［トラスツズマブ後続３］.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.